Research and development

The Company has strong proprietary R&D strength, and establishes a R&D management platform synchronized with world-class standards. The Company is committed to intelligent, fast and integrated clinical laboratory products with easy operations; relying on outstanding R&D capabilities, through continuous technological innovation, has basically formed the three-technology-platform based on atomic absorption spectrometry technology in clinical application for rapid detection of human element, immunofluorescence technology in clinical application for rapid detection, and microfluidic molecular detection application technology; and successfully achieves the industrialization of products related to above-mentioned R&D platforms.

Research and development

Wherein atomic absorption spectrometry technology in clinical application for rapid detection of human element, was first developed by Bohui and applied in medical testing & diagnostic industry, which promotes its wide range of applications in the medical detection and diagnosis industry. Bohui's human element detection system becomes a leading enterprise in this field with its advantages of being precise and fast.